Shares of Endeavour Silver (TSX: EDR) snapped back 6.0% to CA$11.57 on July 9 after the market digested a strong Q2 2026 production report released the prior day. The rally partially recovers a steep slide from $12.52 just last week, driven by softer silver prices and risk-off sentiment — but investors now face a harder question: whether the company's aggressive ramp-up can outrun persistent grade headwinds at its legacy mine.
Two New Mines Carried the Quarter — and It Isn't Close. On a consolidated basis, silver production rose 31% and gold production 35% year-over-year, with silver-equivalent output up 36%.
Terronera contributed 608,347 silver ounces with improving recoveries, while Kolpa's plant expansion lifted throughput to 233,408 tonnes and increased Q2 silver production 19% and silver-equivalent output 26% versus Q1 2026. These two assets now represent the vast majority of Endeavour's growth engine.
First-Half Output Puts Full-Year Guidance Within Reach. First-half silver-equivalent production reached 6,779,737 ounces, up 54% from 2025.
Full-year guidance calls for 8.3–8.9 million ounces of silver and 46,000–48,000 ounces of gold, totaling 14.6–15.6 million silver equivalent ounces. At the current pace, the company is tracking at the upper half of that range. Management plans to move Terronera into higher-grade areas in Q3 2026 , which could accelerate momentum.
The Grade Problem at Guanaceví Isn't Going Away. Silver production at Guanaceví was 30% lower than Q2 2025, predominantly due to 35% lower silver grades. That weakness matters because it pressures per-ounce costs even as volume grows. Guanaceví's all-in sustaining cost — the total expense to produce each ounce — is guided at $29–$30, roughly in line with 2025 levels , well above Kolpa's projected $22–$23.
The Balance Sheet Buys Time, but Costs Are the Next Test. In Q1, the company posted $64.9 million in profit and boosted cash to $231.8 million.
Quarterly revenue surged 230% from a year earlier to $209.7 million. The real test arrives July 29, when Q2 financials will reveal whether volume gains are translating into margin improvement or being eaten by cost inflation. The most recent analyst price target sits at C$17.00 — roughly 47% above today's price — but reaching it requires costs to fall as Terronera scales, not just ounces to rise.